| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* From the Department of Anesthesia and
Biostatistics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Address correspondence to: Dr Anil Agarwal, Type IV/48, SGPGIMS, Lucknow 226 014, India. Fax: +91 522 2668017, 2668047, 2668078; E-mail: aagarwal{at}sgpgi.ac.in
| Abstract |
|---|
|
|
|---|
Methods: Two hundred patients aged 1860 yr, undergoing elective laparoscopic cholecystectomy were randomized into four groups of 50 each. Group I served as control, while Groups II, III and IV received an aerosol inhalation of salbutamol, beclomethasone or sodium chromoglycate 15 min prior to entering the operating room. Following iv fentanyl (2 µgkg-1) the incidence of cough was recorded and graded as mild (12), moderate (35) and severe (> 5) depending on the number of coughs observed. Results were analyzed using z and Fischers Exact test. A P value of
0.05 was considered significant.
Results: The incidence of cough was 28% in the control group, 6%, 0% and 4% in the salbutamol, beclomethasone and sodium chromoglycate groups respectively. Occurrence of cough was significantly low (P
0.05) in the treatment groups, however the difference amongst the groups was not significant (P
0.05).
Conclusion: The use of salbutamol, beclomethasone or sodium chromoglycate aerosol 15 min prior to iv fentanyl administration minimizes fentanyl-induced coughing.
| Introduction |
|---|
|
|
|---|
The various mechanisms proposed to explain fentanyl-induced cough are: inhibition of central sympathetic outflow leading to vagal predominance,7 histamine release, deformation of the tracheobronchial wall stimulating the irritant receptors leading to reflex bronchoconstriction and cough.8,9 Salbutamol, beclomethasone and sodium chromoglycate are used routinely in the management of bronchospasm. Therefore, we postulated that aerosol inhalation of these drugs would prevent fentanyl-induced cough.
| Material and methods |
|---|
|
|
|---|
Two hundred ASA I and II patients of either sex, aged between 1860 yr, scheduled for elective laparoscopic cholecystectomy under general anesthesia were randomly assigned into four groups of 50 each using a computer generated table of random numbers. Group I served as control and did not receive any treatment while patients belonging to Groups II, III and IV inhaled one metered aerosol puff of salbutamol, beclomethasone or sodium chromoglycate 15 min prior to entering the operating room. Patients having a history of chronic obstructive airway disease, an upper respiratory infection in the last two weeks, chronic smoking or recent intake of angiotensin converting enzyme inhibitors, bronchodilators or steroids were excluded from the study.
In the operating room venous access was established. Monitoring consisted of electrocardiogram, non-invasive blood pressure, oxygen saturation and capnography. A fentanyl bolus of 2 µgkg-1 was given iv over a period of five seconds following which the incidence of cough, if any, was recorded by another anesthesiologist who was blinded to drug therapy. Depending upon the number of coughs observed it was graded as mild (12), moderate (35) and severe (> 5). Induction of anesthesia was commenced once cough subsided.
Considering the expected incidence of cough following iv fentanyl to be 35% and assuming a reduction up to 10% following any of the treatments and a power of 80%, the minimum sample size required in each group was 43. Anticipating some variability in reduction we included 50 patients in each group. Patients characteristics were compared by unpaired Students t test. Comparisons between groups were performed for overall incidence of coughing by z test. Coughing was further compared separately at various levels of severity by Fischers Exact test. A P < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
0.05) in the control group when compared to any of the treatment groups (Table II
|
|
| Discussion |
|---|
|
|
|---|
In our study, fentanyl (2 µgkg-1) induced cough in 28% of control patients. Bohrer et al., in a study of 150 patients undergoing coronary artery bypass grafting, observed a 45% incidence of cough when fentanyl (7 µgkg-1) was administered via a central venous catheter.5 The higher incidence could be due to the larger dose and the central route used by Bohrer et al. Lui et al. reported a 46% incidence of fentanyl-induced cough using a dose of 5 µgkg-1.11 In another study, Phua et al. observed a 28% incidence of cough following 1.5 µgkg-1 iv fentanyl injected through a peripheral venous cannula.6 The latter observations are similar to our finding.
Various mechanisms have been proposed to explain fentanyl-induced cough. Fentanyl has been shown to inhibit central sympathetic outflow causing activation of the vagus nerve, inducing cough and reflex bronchoconstriction.7 Lui et al. hypothesized that fentanyl-induced cough is due to bronchoconstriction.11 They evaluated the effects of nebulized terbutaline (B2 agonist) and concluded that terbutaline inhalation effectively suppressed the cough response from 43% to 3%. Salbutamol inhalation causes bronchodilation and is also an effective antitussive agent both in normal and asthmatic patients. Inhalation of a metered dose of salbutamol significantly decreased the incidence of cough in our study.
In humans, fentanyl constricts the tracheal smooth muscle and hence the irritant receptors nearby may be stimulated following deformation of the tracheobronchial wall.9 These receptors, when stimulated, can trigger the cough reflex via the vagal afferent pathway. We used corticosteroid (beclomethasone) inhalation therapy as it is known to reduce bronchial hyperirritability, mucosal edema and also to suppress the inflammatory response to trigger stimuli.12 None of the patients who received beclomethasone inhalation had any cough following a preinduction bolus of iv fentanyl.
Histamine release in humans from lung mast cells is a possible mechanism of fentanyl-induced cough, though this appears very unlikely as fentanyl rarely causes histamine release.13 Sodium chromoglycate inhibits degranulation of mast cells triggered by various stimuli. The release of histamine, leukotrienes, interleukins and other inflammatory mediators from mast cells may be responsible for coughing. Metered dose inhalation of sodium chromoglycate significantly decreased the incidence of cough in our study.
We conclude that pretreatment with salbutamol, beclomethasone or sodium chromoglycate aerosol prior to a 2 µgkg-1 iv fentanyl bolus reduces the incidence of cough. Therefore, we recommend that all patients likely to experience adverse events associated with fentanyl-induced cough should receive a metered dose of one of these drugs by inhalation 15 min prior to induction of anesthesia.
Revision received November 29, 2002. Accepted for publication September 16, 2002.
| References |
|---|
|
|
|---|
2 Grell FL, Koons RA, Denson JS. Fentanyl in anesthesia: a report of 500 cases. Anesth Analg 1970; 49: 52332.
3 Bovill JG, Sebel PS, Stanley TH. Opioid analgesics in anesthesia: with special reference to their use in cardiovascular anesthesia. Anesthesiology 1984; 61: 73155.[Medline]
4 Tweed WA, Dakin D. Explosive coughing after bolus fentanyl injection. Anesth Analg 2001; 92: 14423.
5 Bohrer H, Fleischer F, Werning P. Tussive effect of a fentanyl bolus administered through a central venous catheter. Anaesthesia 1990; 45: 1821.[Medline]
6 Phua WT, Teh BT, Jong W, Lee TL, Tweed WA. Tussive effect of a fentanyl bolus. Can J Anaesth 1991; 38: 3304.
7 Reitan JA, Stengert KB, Wymore ML, Martucci RW. Central vagal control of fentanyl-induced bradycardia during halothane anesthesia. Anesth Analg 1978; 57: 316.
8 Stellato C, Cirillo R, de Paulis A, et al. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Anesthesiology 1992; 77: 93240.[Medline]
9 Yasuda I, Hirano T, Yusa T, Satoh M. Tracheal constriction by morphine and by fentanyl in man. Anesthesiology 1978; 49: 1179.[Medline]
10 Newman SP, Pavia D, Moren F, Sheahan NF, Clarke SW. Deposition of pressurised aerosols in the human respiratory tract. Thorax 1981; 36: 525.
11 Lui PW, Hsing CH, Chu YC. Terbutaline inhalation suppresses fentanyl-induced coughing. Can J Anaesth 1996; 43: 12169.
12 Fanta CH, Rossing TH, McFadden ER Jr. Glucocorticoids in acute asthma. A critical controlled trial. Am J Med 1983; 74: 84551.[Medline]
13 Flacke JW, Flacke WE, Bloor BC, Van Etten AP, Kripke BJ. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 1987; 66: 72330.
This article has been cited by other articles:
![]() |
T. Oshima, Y. Kasuya, Y. Okumura, T. Murakami, and S. Dohi Identification of independent risk factors for fentanyl-induced cough: [L'identification de facteurs de risque independants pour la toux induite par le fentanyl]. Can J Anesth, August 1, 2006; 53(8): 753 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. Lin, C.-C. Yeh, M.-S. Lee, C.-T. Wu, S.-L. Lin, and C.-S. Wong Prolonged Injection Time and Light Smoking Decrease the Incidence of Fentanyl-Induced Cough Anesth. Analg., September 1, 2005; 101(3): 670 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Pandey, M. Raza, R. Ranjan, V. Singhal, M. Kumar, A. Lakra, D. V. Navkar, A. Agarwal, R. B. Singh, U. Singh, et al. Intravenous lidocaine 0.5 mg{middle dot}kg-1 effectively suppresses fentanyl-induced cough: [L'administration iv de 0,5 mg{middle dot}kg-1 de lidocaine supprime efficacement la toux induite par le fentanyl] Can J Anesth, February 1, 2005; 52(2): 172 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Pandey, M. Raza, R. Ranjan, A. Lakra, A. Agarwal, U. Singh, R. B. Singh, and P. K. Singh Intravenous Lidocaine Suppresses Fentanyl-Induced Coughing: A Double-Blind, Prospective, Randomized Placebo-Controlled Study Anesth. Analg., December 1, 2004; 99(6): 1696 - 1698. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Lin, W.-Z. Sun, W.-H. Chan, C.-J. Lin, H.-M. Yeh, and M. S. Mok Intravenous lidocaine and ephedrine, but not propofol, suppress fentanyl-induced cough: [L'administration iv de lidocaine et d'ephedrine, mais non de propofol, supprime la toux causee par le fentanyl] Can J Anesth, August 1, 2004; 51(7): 654 - 659. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |